Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial.
Journal: Cancer treatment and research communications
Published: June 10, 2024
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.
Journal: Journal for immunotherapy of cancer
Published: June 28, 2023
Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 05, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.
Journal: Cancer immunology, immunotherapy : CII
Published: March 07, 2022
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma.
Journal: Melanoma research
Published: July 01, 2021
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 15, 2020
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.
Journal: Annals of surgical oncology
Published: September 25, 2020
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: July 21, 2020
Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.
Journal: Cancer immunology, immunotherapy : CII
Published: March 03, 2020
Chemoprevention in familial adenomatous polyposis: past, present and future.
Journal: Familial cancer
Published: February 19, 2020
Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 30, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026